上海之江生物科技股份有限公司关于开立募集资金专户并签订募集资金专户监管协议的公告

Core Viewpoint - Shanghai Zhijiang Biological Technology Co., Ltd. has established a special account for the management of raised funds and signed a regulatory agreement to ensure the proper use of these funds for its investment projects, specifically the "Japanese Intelligent Manufacturing Project" [3][5]. Fundraising Basic Information - The company was approved for its initial public offering (IPO) on November 27, 2020, by the China Securities Regulatory Commission, allowing it to issue 48.676088 million shares at a price of RMB 43.22 per share, raising a total of RMB 2,103.78 million, with a net amount of RMB 1,942.32 million after deducting issuance costs [2]. Special Account Opening and Regulatory Agreement - A special account for the raised funds has been opened at China Merchants Bank, specifically for the Japanese Intelligent Manufacturing Project, with the account balance being RMB 0 as of September 25, 2025 [3][4]. - The agreement involves three parties: the company, China Merchants Bank, and Guotai Junan Securities Co., Ltd., to ensure compliance with relevant laws and protect investor rights [3][5]. Main Contents of the Regulatory Agreement - The special account is exclusively for the storage and use of funds related to the designated project and cannot be used for other purposes [3][4]. - Guotai Junan Securities, as the sponsor, is responsible for supervising the use of the raised funds and must conduct at least biannual inspections of the account [5][6]. - The agreement stipulates that if the company withdraws more than RMB 500 million or 20% of the net raised funds within 12 months, it must notify the sponsor and provide a detailed expenditure list [6][7]. Agreement Validity and Termination - The agreement becomes effective upon signing and remains valid until all funds are spent and the account is closed [6][7]. - If the agreement is terminated early, the company must sign a new agreement within one month and announce it promptly [6][7].